<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03106805</url>
  </required_header>
  <id_info>
    <org_study_id>EAIUD</org_study_id>
    <nct_id>NCT03106805</nct_id>
  </id_info>
  <brief_title>Early Versus Late Interval Postpartum Copper Intrauterine Device Insertion</brief_title>
  <official_title>Early (4th Week) Versus Late (6thweek) Interval Postpartum Copper Intrauterine Device Insertion: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The optimal interval between pregnancies is debated, but a duration greater than 11-18 months&#xD;
      has been suggested as reducing complications in the subsequent pregnancy. Improved birth&#xD;
      spacing can be a key benefit use of long-acting reversible contraception, but delay to&#xD;
      initiation can still be problematic.So women who have recently given birth can be&#xD;
      cost-effectively targeted for family planning education and engagement because often they are&#xD;
      already connected with health professionals&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of participants use the device</measure>
    <time_frame>6 weeks</time_frame>
    <description>number of women place the intrauterine device within 6 weeks</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">486</enrollment>
  <condition>Contraception Behavior</condition>
  <arm_group>
    <arm_group_label>insertion by the end of the 4th week postpartum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>insertion by the end of the 6th week postpartum</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>early insertion</intervention_name>
    <description>insertion at 4th postpartum week</description>
    <arm_group_label>insertion by the end of the 4th week postpartum</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>late insertion</intervention_name>
    <description>insertion at 6th postpartum week</description>
    <arm_group_label>insertion by the end of the 6th week postpartum</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Delivered (vaginal or Cesarean) a singleton living baby â‰¥28weeks gestation. Women desire&#xD;
        birth spacing for one year or more. Women who will accept to participate in the study and&#xD;
        follow up.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Known uterine anomalies.&#xD;
&#xD;
          2. Women with previous ectopic pregnancy.&#xD;
&#xD;
          3. Presence of postpartum pyrexia.&#xD;
&#xD;
          4. Women with history of postpartum hemorrhage in the last delivery either primary or&#xD;
             secondary.&#xD;
&#xD;
          5. Retained products of conception.&#xD;
&#xD;
          6. History of previous uterine perforation.&#xD;
&#xD;
          7. Anticipation of difficulty of subsequent follow-up with the women.&#xD;
&#xD;
          8. Women with uncontrolled diabetes and hypertension.&#xD;
&#xD;
          9. Women who wish to use other contraceptive methods.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Abbas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Omar Shaaban, MD</last_name>
    <phone>0020123971457</phone>
    <email>omshaaban2000@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assiut Faculty of Medicine</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed Abbas, MD</last_name>
      <email>bmr90@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Shachar BZ, Mayo JA, Lyell DJ, Baer RJ, Jeliffe-Pawlowski LL, Stevenson DK, Shaw GM. Interpregnancy interval after live birth or pregnancy termination and estimated risk of preterm birth: a retrospective cohort study. BJOG. 2016 Nov;123(12):2009-2017. doi: 10.1111/1471-0528.14165. Epub 2016 Jul 13.</citation>
    <PMID>27405702</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 4, 2017</study_first_submitted>
  <study_first_submitted_qc>April 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2017</study_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Mohamed Abbas</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>intrauterine device</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

